Related Experiment Videos

Mortality associated with irinotecan plus bolus fluorouracil/leucovorin

Harry Bleiberg, Angelo Di Leo

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology

|February 15, 2002

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

A phase III trial of alpelisib + trastuzumab ± fulvestrant versus trastuzumab + chemotherapy in HER2+ PIK3CA-mutated breast cancer.

Future oncology (London, England)·2022

Chemotherapy and Targeted Therapy for Patients With Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer That is Either Endocrine-Pretreated or Hormone Receptor-Negative: ASCO Guideline Update.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2021

The prognostic relevance of HER2-positivity gain in metastatic breast cancer in the ChangeHER trial.

Scientific reports·2021

A Serum Metabolomics Classifier Derived from Elderly Patients with Metastatic Colorectal Cancer Predicts Relapse in the Adjuvant Setting.

Cancers·2021

Genomic and Transcriptomic Analyses of Breast Cancer Primaries and Matched Metastases in AURORA, the Breast International Group (BIG) Molecular Screening Initiative.

Cancer discovery·2021

Circulating Biomarkers of CDK4/6 Inhibitors Response in Hormone Receptor Positive and HER2 Negative Breast Cancer.

Cancers·2021

See all related articles